Guo Ling-Li, Yu Su-Yang, Li Meng
Department of Colorectal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China.
Int J Mol Med. 2016 Jul;38(1):300-4. doi: 10.3892/ijmm.2016.2617. Epub 2016 May 31.
The aim of the present study was to explore the functions of histone acetyltransferase binding to origin recog-nition complex (ORC) 1 (HBO1) during tumor development and to screen for HBO1 inhibitors. The chromatin immuno-precipitation sequencing (ChIP-seq) data of HBO1 in the RKO human colon cancer cell line (GSE33007) were downloaded from the Gene Expression Omnibus (GEO) database. The reads were then mapped back to a reference genome hg19. The PCR duplicate reads were removed by using SAMtools software and the shift was calculated using SPP and MaSC software. The peak calling was carried out using MACS 1.4.0 software. Furthermore, the inhibitors of HBO1 were screened out from the Specs database using Dock 6.6 software. The binding sites of HBO1 were mainly distributed in the intergenic, intronic and 3'-end regions. Further analysis revealed that a total of 9,467 target genes was identified around HBO1 binding sites in the RKO cell lines and those genes mainly participated in the cell cycle, biosynthetic process, as well as other processes. Finally, 5 inhibitors with best binding affinity in the positively charged cavity of HBO1 were screened out: i) 5-[(2-hydroxybenzylidene)amino] -2-(2‑{4‑[(2‑hydroxy-benzylidene)amino]-2-sulfonatophenyl}vinyl)benzenesulfonate, ii) 3-[4-(3-bromo-4-{2-[4-(ethoxycarbonyl)anilino]-2-oxo-ethoxy}-5-methoxybenzylidene)‑3‑methyl‑5‑oxo -4,5-dihydro-1H-pyrazol-1-yl]benzoic acid, iii) 4-(4-{3-iodo‑5‑ methoxy‑4-[2-(2-methoxyanilino)-2-oxoethoxy]benzylidene}-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid, iv) 5-chloro-1,3-bis{[3,5,6-trihydroxy-4-(octyloxy)tetrahydro-2H-pyran-2-yl]methyl}-1,3-dihydro-2H-benzimidazol-2-one and v) 4-{[4-(tetradecylamino)-1-naphthyl]diazenyl}benzoic acid. As a whole, in this study, we identified the possible binding sites and biological functions of HBO1. The potential inhibitors of HBO1 were also screened, which prove to be helpful for the inhibition of HBO1 during tumor development.
本研究旨在探讨组蛋白乙酰转移酶与起始识别复合物(ORC)1(HBO1)结合在肿瘤发生发展过程中的作用,并筛选HBO1抑制剂。从基因表达综合数据库(GEO)下载了RKO人结肠癌细胞系中HBO1的染色质免疫沉淀测序(ChIP-seq)数据(GSE33007)。然后将读数映射回参考基因组hg19。使用SAMtools软件去除PCR重复读数,并使用SPP和MaSC软件计算偏移量。使用MACS 1.4.0软件进行峰检测。此外,使用Dock 6.6软件从Specs数据库中筛选出HBO1的抑制剂。HBO1的结合位点主要分布在基因间、内含子和3'端区域。进一步分析显示,在RKO细胞系中,围绕HBO1结合位点共鉴定出9467个靶基因,这些基因主要参与细胞周期、生物合成过程以及其他过程。最后,筛选出在HBO1带正电荷的腔内具有最佳结合亲和力的5种抑制剂:i)5-[(2-羟基亚苄基)氨基]-2-(2-{4-[(2-羟基亚苄基)氨基]-2-磺酰基苯基}乙烯基)苯磺酸盐,ii)3-[4-(3-溴-4-{2-[4-(乙氧基羰基)苯胺基]-2-氧代乙氧基}-5-甲氧基亚苄基)-3-甲基-5-氧代-4,5-二氢-1H-吡唑-1-基]苯甲酸,iii)4-(4-{3-碘-5-甲氧基-4-[2-(2-甲氧基苯胺基)-2-氧代乙氧基]亚苄基}-3-甲基-5-氧代-4,5-二氢-1H-吡唑-1-基)苯甲酸,iv)5-氯-1,3-双{[3,5,6-三羟基-4-(辛氧基)四氢-2H-吡喃-2-基]甲基}-1,3-二氢-2H-苯并咪唑-2-酮和v)4-{[4-(十四烷基氨基)-1-萘基]重氮基}苯甲酸。总体而言,在本研究中,我们确定了HBO1可能的结合位点和生物学功能。还筛选出了HBO1的潜在抑制剂,这被证明有助于在肿瘤发生发展过程中抑制HBO1。